John F. Crowley, President and Chief Executive Officer of Amicus Therapeutics (FOLD), will preside over the closing bell to celebrate the Company’s initial public offering on NASDAQ.
John F. Crowley, President and Chief Executive Officer of Amicus Therapeutics (FOLD), will preside over the closing bell to celebrate the Company’s initial public offering on NASDAQ.
